Keith J. Harrison

 Partner Washington, D.C.
Phone: +1 202.624.2560
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Keith J. Harrison is a trial lawyer and a partner in the firm's Washington, D.C. office. A former New York City prosecutor, Keith has tried over 70 cases in eight states and the District of Columbia, and argued 12 cases in courts of appeal. He represents companies, boards of directors and senior executives in investigations, sensitive matters, corporate crises, litigation and other disputes involving the federal and state governments including the Department of Justice, District Attorney's Offices, State Attorneys General, other law enforcement and regulatory agencies, and the United States Congress. Keith maintains a diverse litigation practice, focused on the highly regulated industries, like the pharmaceutical, defense contracting, and aviation industries. He has been repeatedly selected as a Washington, D.C. "Super Lawyer" in the field of civil litigation and intellectual property litigation by Super Lawyers, from 2007 through 2018. Keith is also the co-chair of the firm's Public Service Practice Group and a member of the firm's Diversity Council.

At Crowell & Moring, Keith litigates False Claims Act (FCA), antitrust, intellectual property, anti-kickback, FCPA, RICO, and other complex cases, and he represents clients in grand jury investigations and other proceedings before the DOJ. He has extensive experience navigating clients through Congressional investigations and hearings. Keith also devotes a considerable portion of his practice to compliance counseling and training companies on reducing false claims, antitrust, anti-kickback, FCPA, and other litigation risks.

For over a decade, Keith has been a faculty member of the National Institute for Trial Advocacy, and was one of the founders of Crowell's in-house Trial Excellence Academy, two institutions where lawyers learn the art of trial advocacy.

Notable Current Matters

  • Represents a pharmaceutical company in nation-wide class action multi-district litigation alleging antitrust violations.
  • Represents as lead trial counsel a major U.S. airline in a multi-million dollar FAA regulatory dispute with the Port Authority of New York and New Jersey.
  • Represents as lead trial counsel a major U.S. airline in a qui tam whistleblower lawsuit alleging False Claims Act violations involving the maintenance of Air Force C-17 aircraft engines.
  • Represents a pharmaceutical company in a criminal antitrust investigation.

Other Notable Matters

False Claims Act/Whistleblower Litigation

  • Lead national trial counsel for one of the world's largest generic drug manufacturers in the nationwide Average Wholesale Price litigation. During this time, Keith has coordinated the defense of more than 15 separate lawsuits pending in state and federal courts around the country, including a qui tam action under the Federal False Claims Act and numerous civil enforcement actions brought by state attorney general's alleging violations of a variety of state statutes, including state false claims acts.
  • Successfully represented a brand pharmaceutical company in a False Claims Act case alleging off-label marketing and FCA violations.
  • Successfully represented as lead trial counsel a major defense contractor in a FCA case brought by DOJ alleging false claims under an Army contract for trucks
  • Successfully represented as lead trial counsel a major telecommunications company in multiple state FCA claims based on alleged underpayment of taxes used to support 911 emergency services
  • Successfully represented government defense contractor against allegations of fraudulent overcharging on aircraft armament firing systems.
  • Successfully represented, during a three-week jury trial, a government contractor accused of criminal false claims and money laundering related to the shipment of U.S. military equipment to Egypt under the Camp David Peace Accords and Foreign Military Sales program. 
  • Successfully represented as lead trial counsel a major university in a whistleblower lawsuit that settled on the eve of trial.
  • Successfully represented a lead trial and appellate counsel a major hospital in a whistleblower case obtaining dismissal that was upheld on appeal in the leading case interpreting the District of Columbia’s public policy exception to at-will employment, Kassem v. Washington Hospital Center, 513 F.3d 251 (D.C. Cir. 2008).

Pharmaceutical Industry Litigation

  • Represented Sun/Caraco when the FDA used U.S. Marshalls to seize over $24 million of allegedly adulterated drug products based on cGMP violations. The regulatory enforcement litigation with DOJ in Detroit Michigan was quickly resolved by negotiating a consent decree
  • Lead trial counsel in MorphoSys v. Cambridge Antibody Technology, where Keith successfully tried a three-week biotech patent infringement jury trial regarding phage display antibody library technology, the technology that eventually led to the blockbuster biologic drug HUMIRA®.
  • Lead trial counsel in Celera Genomics v. Wyeth, Inc., a jury trial concerning Celera's historic decoding of the human genome and the licensing of its genetic database, which settled successfully after Keith's opening statement.

Aviation Litigation

  • Represents airlines in disputes involving allegations of discrimination when airlines remove passengers identified as being security risks by the TSA.
  • Successfully resolved FAA enforcement proceedings against various airlines.
  • Obtained a TRO enjoining the sale of a commercial jet airliner in federal court.

Antitrust Litigation

  • Represented a major U.S. railroad company in antitrust litigation alleging price-fixing of fuel surcharges.
  • Represented AT&T in antitrust litigation bought by several phone companies alleging monopolization of essential facilities and refusal to deal in violation of Section 2 of the Sherman Act.
  • Won an arbitration victory against a world-renowned physician who claimed that a major hospital system was violating Section 1 of the Sherman Act in its relationships with physicians.

Affirmative Recovery Actions

  • Developed a strategy for recovering Federal government underpayments to health plans participating in the Federal Employee Health Benefits Program (FEHBP). Eventually, over $350 million dollars in FEHBP underpayments were recovered for various health plans.

Congressional Investigations

  • Successfully represented a pharmaceutical company in a Congressional investigation into the rising prices of certain generic drugs.
  • Represented Cotecna Inspection, S.A. and certain individual employees during the House, Senate and United Nations Volker Commission investigation into the U.N. Oil for Food Program and whether Cotecna's hiring of the U.N. Secretary General Kofi Annan's son, Kojo Annan, was an illegal kickback.
  • Represented a key witness testifying before the Cole Inquiry, a Royal Commission that investigated the Australian Wheat Board Oil-for-Wheat scandal (also known just as the AWB scandal) involving the payment of kickbacks to the regime of Saddam Hussein in contravention of the United Nations Oil-for-Food Humanitarian Program. The AWB was the biggest single source of kickbacks made to the Iraqi government and the scandal was the biggest bribery scheme in Australian history.
  • Represented the Executive Director of a trade association in an investigation by the House Energy and Commerce Subcommittee on Oversight and Investigations into waste, fraud and abuse in the Federal E-rate Program and DOJ investigation into violations of the antitrust laws.

Corporate Compliance and Internal Investigations

  • Keith has decades of experience in conducting confidential investigations that have ranged from Major League Baseball's investigation of Pete Rose to the United Nations Iraq Oil for Food Program.
  • Currently conducting internal investigations of potential FCA violations for companies in the pharmaceutical, and aviation industries.
  • Conducted internal investigations regarding missing funds from a major armored car company.
  • Conducted internal investigations regarding allegations of sexual harassment against a corporate CEO.
  • Conducted an internal investigation of a Department Chairman of a major hospital system for fraud related to medical accreditation activities.
  • Based on his prosecutorial experience and broad and regulatory litigation experience, many clients look to Keith to establish, review or revise their corporate compliance programs, conduct compliance training or conduct internal investigations.

Administrative Litigation

  • Recently represented the world's largest water treatment company in obtaining a temporary restraining order (TRO) and then a permanent injunction against the EPA and DOJ that prevented the federal government from enforcing a stop-sale order and allowed a multi-million dollar water treatment technology back on the market.

Pro Bono and Community Service

As co-chair of Crowell & Moring's Public Service Practice Group, Keith oversees the firm's pro bono program. Keith is also currently the Chairman of the Board of BEST Kids, Inc. a nonprofit organization that recruits, trains and supports mentors for D.C.'s foster care youth. He has also been a volunteer youth soccer, basketball, and softball coach. Keith has recently handled significant pro bono matters, including:

  • Lead trial counsel seeking to overturn the conviction of an innocent man who was on Florida's Death Row for 20 years.
  • Obtained U.S. asylum for a Christian Pastor and his family from the Democratic Republic of the Congo, who was repeatedly tortured in response to his preaching for social justice and respect for democratic constitutional values.
  • The City Council for the District of Columbia retained Keith to investigate allegations that the D.C. Police Department was failing to investigate and mishandling sexual assault cases. The firm's investigation led to police reforms and new legislation entitled, "Sexual Assault Victims' Rights Act of 2013."


Admitted to practice: District of Columbia, New York

Highlights, News & Knowledge

Speeches & Presentations


Client Alerts & Newsletters

In the News

Firm News & Announcements

Oct.15.2018 Super Lawyers Recognizes 82 Crowell & Moring Lawyers Across United States
Jul.20.2018 Federal Judge Declares: Grant New Trial to Crowell & Moring Client Crosley Green or Set Him Free
Oct.31.2017 Super Lawyers Recognizes 79 Crowell & Moring Lawyers Across United States
Aug.07.2017 Two East Asia Companies Dismiss Lawsuit against FBI
Nov.30.2016 Super Lawyers Recognizes 71 Crowell & Moring Lawyers Across United States
Sep.07.2016 Crowell & Moring Pro Bono: Lawyers’ Committee Files Federal Voting Rights Lawsuit Challenging Discriminatory Method of Electing Judges to Highest Courts in State of Alabama
Oct.27.2015 Super Lawyers Recognizes 90 Crowell & Moring Attorneys
Jun.02.2015 CBS "48 Hours" Features Crowell & Moring Pro Bono Client Crosley Green
Jan.22.2015 Crowell & Moring's Antitrust Group Featured in Global Competition Review's 15th Edition "GCR 100"
Jan.13.2015 Crowell & Moring Releases Third Annual Litigation Forecast Report and Inaugural Regulatory Forecast
Sep.30.2014 Super Lawyers 2014 Recognizes 90 Crowell & Moring Attorneys
Feb.28.2014 Former Florida Death Row Inmate Crosley Green Asks Orlando Federal Court to Overturn His Conviction: Crowell & Moring Files Habeas Corpus
Sep.01.2013 Super Lawyers 2013 Recognizes 64 Crowell & Moring Attorneys
Jun.24.2013 Crowell & Moring Recognized by National Law Journal as Washington, D.C. "General Civil Litigation" Department of the Year
Jul.09.2010 Former Florida Death Row Inmate Crosley Green Petitions For New Trial